While loss of PKM2, which lowers but does not block glycolytic flux, negatively affects hematopoietic progenitor cells (HPCs) and AML cells, hematopoietic stem cells (HSCs) are spared. This evidence concerns the gene PKM and acute myeloid leukemia.